Traditional epidemiological studies have identified numerous potential risk factors, but observational studies have struggled to establish causal links due to confounding factors and reverse causation ...

Transgene has completed patient randomisation in the phase 2 part of its phase 1/2 clinical trial evaluating TG4050, an individualised neoantigen therapeutic vaccine being developed for the adjuvant ...

The comparison of publications/citations in Mendelian randomisation from 2015 to 2024. On the top, it reflects the trend of total publications and citations each year. The keywords in this field are ...

Phase 3 Mascot study reaches key milestone for potential first-in-class therapy Lundbeck has announced that the final patient has been randomised ahead of schedule in its global phase 3 Mascot trial, ...